Balchem ( (BCPC) ) has released its Q1 earnings. Here is a breakdown of the information Balchem presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Balchem Corporation is a company operating in the human and animal nutrition and health sectors, as well as specialty products, known for its innovative solutions in these industries.
In the first quarter of 2025, Balchem Corporation reported strong financial results with record net sales and adjusted EBITDA, reflecting growth across all its business segments. The company also launched a new corporate website and released its 2024 Sustainability Report, emphasizing its commitment to global health and nutrition.
Key financial highlights include a 4.5% increase in net sales to $250.5 million and a 27.8% rise in net earnings to $37.1 million. The company achieved record adjusted EBITDA of $66.3 million, up 8.9% from the previous year. Each of its segments—Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products—showed sales and earnings growth, contributing to the overall positive performance.
The Human Nutrition and Health segment saw a 3.7% increase in sales, while the Animal Nutrition and Health segment experienced a 6.2% rise. The Specialty Products segment also grew by 5.3%, driven by higher sales in performance gases and plant nutrition. Balchem’s gross margin improved by 8.2%, and operating expenses decreased, enhancing profitability.
Looking ahead, Balchem’s management remains optimistic about the company’s growth prospects despite global trade uncertainties. The focus will continue to be on strategic growth initiatives to sustain momentum throughout 2025 and beyond.